Drug Patents owned by Handa

1. Drug name - TASCENSO ODT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9925138 HANDA Stable solid fingolimod dosage forms Jan, 2036

(13 years from now)

US10555902 HANDA Stable fingolimod dosage forms Jan, 2036

(13 years from now)

US10925829 HANDA Stable solid fingolimod dosage forms Jan, 2036

(13 years from now)

Drugs and Companies using FINGOLIMOD LAURYL SULFATE ingredient

Treatment: Treatment of multiple sclerosis in pediatric patients 10 years of age and older and weighing less than or equal to 40 kg

Dosage: TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 0.25MG BASE TABLET, ORALLY DISINTEGRATING;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.